SCHEMBL25199306

SCHEMBL25199306

CNc1nc(Cl)nc2c1c(-c1ccn3nccc3n1)cn2S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.36
YTHDC1 Q96MU7 1/20 0.36
BRD4 O60885 1/20 0.35
TGFBR1 P36897 3/20 0.34
PIK3CD O00329 1/20 0.34
NAMPT P43490 1/20 0.33
ALDH1A1 P00352 2/20 0.32
RAPGEF4 Q8WZA2 1/20 0.32
GRM4 Q14833 1/20 0.32
KDM4E B2RXH2 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTT P42858 1/20 0.31
HTR6 P50406 1/20 0.31
PKM P14618 1/20 0.30
DYRK1A Q13627 1/20 0.30
FLT3 P36888 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30349312 1.00 L3MBTL1 (0.36) L3MBTL1YTHDC1BRD4TGFBR1PIK3CD
SCHEMBL30349368 0.82 MERTK (0.35) L3MBTL1PIK3CDNAMPTFLT3
SCHEMBL25523145 0.80 PIM1 (0.33) L3MBTL1NAMPTFLT3
SCHEMBL25202444 0.80 PIM1 (0.33) L3MBTL1NAMPTFLT3
SCHEMBL30349145 0.80 PIM1 (0.33) L3MBTL1NAMPTFLT3
SCHEMBL1019268 0.79 YTHDC1 (0.38) L3MBTL1YTHDC1BRD4ALDH1A1GRM4
SCHEMBL1021382 0.78 HTR6 (0.40) L3MBTL1YTHDC1MAPTHTR6
SCHEMBL25204252 0.75 CA1 (0.43) L3MBTL1YTHDC1BRD4ALDH1A1RAPGEF4
SCHEMBL1016690 0.75 YTHDC1 (0.41) L3MBTL1YTHDC1BRD4ALDH1A1RAPGEF4
SCHEMBL25157531 0.70 TGFBR1 (0.38) TGFBR1PIK3CDDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129104-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2025-04-24 US disclosed
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 US disclosed
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 US disclosed
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 L3MBTL1 2548/4885YTHDC1 1583/4885BRD4 1417/4885
US-20250129104-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 L3MBTL1 2548/4885YTHDC1 1583/4885BRD4 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.